BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27694322)

  • 1. Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.
    Dagklis A; Demeyer S; De Bie J; Radaelli E; Pauwels D; Degryse S; Gielen O; Vicente C; Vandepoel R; Geerdens E; Uyttebroeck A; Boeckx N; de Bock CE; Cools J
    Blood; 2016 Dec; 128(23):2642-2654. PubMed ID: 27694322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
    Bongiovanni D; Tosello V; Saccomani V; Dalla Santa S; Amadori A; Zanovello P; Piovan E
    Oncogene; 2020 Oct; 39(42):6544-6555. PubMed ID: 32917954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
    Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gant61 ameliorates CCl
    Jiayuan S; Junyan Y; Xiangzhen W; Zuping L; Jian N; Baowei H; Lifang J
    Toxicol Appl Pharmacol; 2020 Jan; 387():114853. PubMed ID: 31816328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic landscape and ligand-dependent activation of sonic hedgehog-Gli1 signaling in chordomas: a novel therapeutic target.
    Yang C; Yong L; Liang C; Li Y; Ma Y; Wei F; Jiang L; Zhou H; He G; Pan X; Hai B; Wu J; Xu Y; Liu Z; Liu X
    Oncogene; 2020 Jun; 39(24):4711-4727. PubMed ID: 32404987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5'AMP-Activated Kinase Inactivation.
    Tosello V; Bongiovanni D; Di Martino L; Franchin C; Zanovello P; Arrigoni G; Piovan E
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of
    Kohara Y; Haraguchi R; Kitazawa R; Imai Y; Kitazawa S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer.
    Riaz SK; Khan JS; Shah STA; Wang F; Ye L; Jiang WG; Malik MFA
    Cell Commun Signal; 2018 Jan; 16(1):3. PubMed ID: 29329585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.
    Moshai EF; Wémeau-Stervinou L; Cigna N; Brayer S; Sommé JM; Crestani B; Mailleux AA
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):11-25. PubMed ID: 24450438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death.
    Wang X; Wei S; Zhao Y; Shi C; Liu P; Zhang C; Lei Y; Zhang B; Bai B; Huang Y; Zhang H
    Cancer Lett; 2017 Jan; 385():128-136. PubMed ID: 27810405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GANT-61 and GDC-0449 induce apoptosis of prostate cancer stem cells through a GLI-dependent mechanism.
    Tong W; Qiu L; Qi M; Liu J; Hu K; Lin W; Huang Y; Fu J
    J Cell Biochem; 2018 Apr; 119(4):3641-3652. PubMed ID: 29231999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
    Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
    Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
    Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
    Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
    Arnhold V; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.
    Williamson AJ; Doscas ME; Ye J; Heiden KB; Xing M; Li Y; Prinz RA; Xu X
    Oncotarget; 2016 Mar; 7(9):10472-85. PubMed ID: 26859575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Hedgehog-Gli1 signaling in the enhanced proliferation and differentiation of MG63 cells enabled by hierarchical micro-/nanotextured topography.
    Lin Y; Huang Y; He J; Chen F; He Y; Zhang W
    Int J Nanomedicine; 2017; 12():3267-3280. PubMed ID: 28458545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoothened is a poor prognosis factor and a potential therapeutic target in glioma.
    Tu Y; Niu M; Xie P; Yue C; Liu N; Qi Z; Gao S; Liu H; Shi Q; Yu R; Liu X
    Sci Rep; 2017 Feb; 7():42630. PubMed ID: 28195165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria.
    Gambassi S; Geminiani M; Thorpe SD; Bernardini G; Millucci L; Braconi D; Orlandini M; Thompson CL; Petricci E; Manetti F; Taddei M; Knight MM; Santucci A
    J Cell Physiol; 2017 Nov; 232(11):3103-3111. PubMed ID: 28019670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
    Shahi MH; Farheen S; Mariyath MP; Castresana JS
    Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.